Researchers at Concordia University in Canada are taking a closer look at oxytocin, a hormone traditionally studied for its role in childbirth and breastfeeding, and more recently for its effect on social behaviour.
The latest study by Mark Ellenbogen and Christopher Cardoso, published in the journal Psychoneuroendocrinology, shows that oxytocin can increase a person's trust in others following social rejection.
Ellenbogen explained that it means that instead of the traditional 'fight or flight' response to social conflict where people get revved up to respond to a challenge or run away from it, oxytocin may promote the 'tend and befriend' response where people reach out to others for support after a stressful event.
In a double-blind experiment, 100 students were administered either oxytocin or a placebo via a nasal spray, then subjected to social rejection.
In a conversation that was staged to simulate real life, researchers posing as students disagreed with, interrupted and ignored the unsuspecting participants.
Using mood and personality questionnaires, the data showed that participants who were particularly distressed after being snubbed by the researchers reported greater trust in other people if they sniffed oxytocin prior to the event, but not if they sniffed the placebo.
Cardoso said that studying oxytocin may provide future options for those who suffer from mental health conditions characterised by high levels of stress and low levels of social support, like depression.
"If someone is feeling very distressed, oxytocin could promote social support seeking, and that may be especially helpful to those individuals," he said, noting that people with depression tend to naturally withdraw even though reaching out to social support systems can alleviate depression and facilitate recovery.
"The next phase of research will begin to study oxytocin's effects in those who are at high risk for developing clinical depression," said Ellenbogen.
"In distressed people, oxytocin may improve one's motivation to reach out to others for support. That idea is cause for a certain degree of excitement, both in the research community and for those who suffer from mood disorders," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
